INS Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £93,125

Instem Insider Trading History Chart

This chart shows the insider buying and selling history at Instem by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Instem Share Price & Price History

Current Price: GBX 670
Price Change: Price Increase of +5 (0.75%)
As of 11/25/2022 01:00 AM ET

This chart shows the closing price history over time for INS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Instem Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2022Nigel GoldsmithInsiderSell12,500GBX 745£93,125
10/11/2021Nigel GoldsmithInsiderBuy2,500GBX 825£20,625
7/17/2020Phil ReasonInsiderSell142,000GBX 435£617,700
6/26/2020David GareInsiderSell40,000GBX 435£174,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Instem (LON:INS)

Instem logo
Instem plc, together with its subsidiaries, provides information technology applications to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Logbook, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a Windows-based system for organizations and universities in non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; SEND Explorer, a web-based application with optional data warehousing capabilities; SENDTrial, a web based solution that can be accessed through a subscription; and standard for exchange of nonclinical data solutions. Further, the company provides Sorcerer Colony Counter for automatic plate counter; sales support, training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; and software solutions to extract intelligence from research and development related healthcare data. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.
Read More on Instem

Today's Range

Now: GBX 670
Low: 650
High: 672

50 Day Range

MA: GBX 630.43
Low: 580
High: 690

52 Week Range

Now: GBX 670
Low: 550
High: 910

Volume

93,475 shs

Average Volume

26,649 shs

Market Capitalization

£152.12 million

P/E Ratio

8,375.00

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Instem?

Instem's top insider investors include:
  1. Nigel Goldsmith (Insider)
Learn More about top insider investors at Instem.